Capital Fund Management S.A. Mirum Pharmaceuticals, Inc. Transaction History
Capital Fund Management S.A.
- $36 Billion
- Q3 2025
A detailed history of Capital Fund Management S.A. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 36,115 shares of MIRM stock, worth $2.58 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,115
Previous 29,275
23.36%
Holding current value
$2.58 Million
Previous $1.49 Million
77.77%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
292Shares Held
57.6MCall Options Held
86.1KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million21.07% of portfolio
-
Janus Henderson Group PLC London, X05MShares$357 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.6MShares$185 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.52MShares$180 Million3.41% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...